M-Phase Phosphoprotein 11 Is a Highly Immunogenic Tumor Antigen in Patients with Acute Myeloid Leukemia

Publisher： Karger

E-ISSN： 1421-9662|127|4|193-197

ISSN： 0001-5792

Source： Acta Haematologica, Vol.127, Iss.4, 2012-03, pp. : 193-197

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Genetic Mutations in Patients with Acute Myeloid Leukemia and Leukostasis

By  

Acta Haematologica, Vol. 130, Iss. 2, 2013-03 ,pp. : 95-97

Karger

Access to resources Recommend Favorite

Phase I/II trial of the combination of midostaurin (PKC412) and 5‐azacytidine for patients with acute myeloid leukemia and myelodysplastic syndrome

By  

AMERICAN JOURNAL OF HEMATOLOGY, Vol. 90, Iss. 4, 2015-04 ,pp. : 276-281

John Wiley & Sons Inc

Access to resources Recommend Favorite

A multicenter, phase II study of maintenance azacitidine in older patients with acute myeloid leukemia in complete remission after induction chemotherapy

By  

AMERICAN JOURNAL OF HEMATOLOGY, Vol. 90, Iss. 9, 2015-09 ,pp. : 796-799

John Wiley & Sons Inc

Access to resources Recommend Favorite

Phase 1 study of quizartinib in combination with induction and consolidation chemotherapy in patients with newly diagnosed acute myeloid leukemia

By  

AMERICAN JOURNAL OF HEMATOLOGY, Vol. 93, Iss. 2, 2018-02 ,pp. : 213-221

John Wiley & Sons Inc

Access to resources Recommend Favorite

A phase I study of lenalidomide plus chemotherapy with mitoxantrone, etoposide, and cytarabine for the reinduction of patients with acute myeloid leukemia

By  

AMERICAN JOURNAL OF HEMATOLOGY, Vol. 93, Iss. 2, 2018-02 ,pp. : 254-261

John Wiley & Sons Inc

Access to resources Recommend Favorite